Blackstone Inc
RLAY icon

Blackstone Inc’s Relay Therapeutics RLAY Stock Holding History

Blackstone Inc’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,618
Closed -$186K – 294
2025
Q3 		$186K Hold
35,618
– – ﹤0.01% 242
2025
Q2 		$123K Hold
35,618
– – ﹤0.01% 165
2025
Q1 		$93.3K Hold
35,618
– – ﹤0.01% 168
2024
Q4 		$147K Hold
35,618
– – ﹤0.01% 160
2024
Q3 		$252K Hold
35,618
– – ﹤0.01% 151
2024
Q2 		$232K Hold
35,618
– – ﹤0.01% 166
2024
Q1 		$296K Hold
35,618
– – ﹤0.01% 161
2023
Q4 		$392K Hold
35,618
– – ﹤0.01% 146
2023
Q3 		$300K Hold
35,618
– – ﹤0.01% 143
2023
Q2 		$447K Hold
35,618
– – ﹤0.01% 138
2023
Q1 		$587K Hold
35,618
– – ﹤0.01% 135
2022
Q4 		$532K Hold
35,618
– – ﹤0.01% 127
2022
Q3 		$797K Hold
35,618
– – ﹤0.01% 133
2022
Q2 		$597K Hold
35,618
– – ﹤0.01% 170
2022
Q1 		$1.07M Hold
35,618
– – ﹤0.01% 167
2021
Q4 		$1.09M Hold
35,618
– – ﹤0.01% 319
2021
Q3 		$1.12M Buy
+35,618
New +$1.2M ﹤0.01% 374

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blackstone Inc's RLAY Position: Q4 2025 in Review

Blackstone Inc sold out of Relay Therapeutics (RLAY) in Q4 2025, closing a stake of 35,618 shares — an estimated $186K sold.

Blackstone Inc first reported a position in RLAY in Q3 2021 and held it in 17 quarters. The position peaked at $1.12M in Q3 2021. 227 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

  • Blackstone Inc reported no remaining Relay Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Blackstone Inc sold 35,618 Relay Therapeutics shares in Q4 2025, an estimated $186K.
  • Blackstone Inc first reported a position in Relay Therapeutics in Q3 2021 and held it in 17 quarters.
  • Blackstone Inc's Relay Therapeutics position peaked at $1.12M in Q3 2021.
  • 227 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on Blackstone Inc's 13F filing for Q4 2025, filed 17 Feb 2026.